ISR Immune System Regulation Holding AB (publ)

OM:ISR Stock Report

Market Cap: SEK 96.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ISR Immune System Regulation Holding Future Growth

Future criteria checks 0/6

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth45.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

We're Not Very Worried About ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Rate

Aug 11
We're Not Very Worried About ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Rate

A Look At The Fair Value Of ISR Immune System Regulation Holding AB (publ) (STO:ISR)

Jul 02
A Look At The Fair Value Of ISR Immune System Regulation Holding AB (publ) (STO:ISR)

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Mar 08
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Nov 18
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Jul 27
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Situation

Mar 26
Here's Why We're Watching ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Situation

We Think ISR Immune System Regulation Holding (STO:ISR) Can Afford To Drive Business Growth

Dec 11
We Think ISR Immune System Regulation Holding (STO:ISR) Can Afford To Drive Business Growth

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ISR Immune System Regulation Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OM:ISR - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2022N/A-213-94-94N/A
9/30/2022N/A-235-111-111N/A
6/30/2022N/A-257-128-128N/A
3/31/2022N/A-168-98-98N/A
12/31/2021N/A-79-67-67N/A
9/30/2021N/A-60-62-62N/A
6/30/2021N/A-41-56-56N/A
3/31/2021N/A-36-53-53N/A
12/31/2020N/A-31-50-50N/A
9/30/2020N/A-29-39-39N/A
6/30/2020N/A-28-28-28N/A
3/31/2020N/A-28-29-29N/A
12/31/2019N/A-29-30-30N/A
9/30/2019N/A-29-28-28N/A
6/30/2019N/A-28-27-27N/A
3/31/2019N/A-25-22-22N/A
12/31/2018N/A-21-17-17N/A
9/30/2018N/A-20-17-17N/A
6/30/2018N/A-18-17-17N/A
3/31/20180-18-18-18N/A
12/31/2017N/A-21-21-21N/A
9/30/2017N/A-30-30-30N/A
6/30/20170-21-21-21N/A
3/31/20170-27-24-24N/A
12/31/20160-14-11-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ISR's forecast earnings growth is above the savings rate (0.5%).

Earnings vs Market: Insufficient data to determine if ISR's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if ISR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ISR's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if ISR's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ISR's Return on Equity is forecast to be high in 3 years time


Discover growth companies